报价延迟最少15分钟:2025/09/17 07:48 EDT
盘前时段
|
||||
|
23.96 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.31/2.55
|
|
企业价值
22.84B
|
| 资产负债 |
|
每股账面净值
14.25
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
14.81B
|
|
每股收益
29.75
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/09/17 07:48 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025. |
